Telesis Bio Inc.

TBIO Healthcare Medical Devices

Telesis Bio Inc.’s revenue for fiscal 2023 (year ended December 2023) was $27.5 million, roughly unchanged from fiscal 2022.

0.01 0.00 0.00%
Market cap
$5.3M
P/E
0.0×
Fwd P/E
−0.2×
Dividend yield
—
F-score
4/9
Altman Z
−4.52
Beneish M
−2.85
Dividend safety
n/a
Older periods Dec '23 Mar '24 Jun '24 Sep '24
Piotroski F-Score

+8 more TTM periods

4 4 2 1
ROE
(209.49%) (332.08%) (1,405.45%) 1,013.88%
ROA
(64.60%) (61.81%) (62.02%) (73.87%)
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(172.23%) (199.13%) (449.42%) (858.27%)
Average Days of Receivables
71.78 44.41 27.77 34.04
Free Cash Flow per Share
(22.07) (17.20) (13.17) (13.45)
Free Cash Flow
(36.63) (28.73) (22.78) (23.85)
Other line items

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026